Omega Fund Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $510K | Hold |
|
|||||
2022
Q4 | $306K | Hold |
|
|||||
2022
Q3 | $645K | Hold |
|
|||||
2022
Q2 | $835K | Hold |
|
|||||
2022
Q1 | $1.87M | Hold |
|
|||||
2021
Q4 | $2.3M | Hold |
|
|||||
2021
Q3 | $2.05M | Hold |
|
|||||
2021
Q2 | $1.87M | Hold |
|
|||||
2021
Q1 | $2.83M | Sell |
|
|||||
2020
Q4 | $2.35M | Hold |
|
|||||
2020
Q3 | $2.73M | Sell |
|
|||||
2020
Q2 | $3.66M | Hold |
|
|||||
2020
Q1 | $2.52M | Hold |
|
|||||
2019
Q4 | $4.63M | Hold |
|
|||||
2019
Q3 | $1.76M | Hold |
|
|||||
2019
Q2 | $2.62M | Hold |
|
|||||
2019
Q1 | $3.29M | Hold |
|
|||||
2018
Q4 | $1.79M | Hold |
|
|||||
2018
Q3 | $3.44M | Hold |
|
|||||
2018
Q2 | $4.06M | Hold |
|
|||||
2018
Q1 | $11.8M | Sell |
|
|||||
2017
Q4 | $7.39M | Hold |
|
|||||
2017
Q3 | $9.03M | Hold |
|
|||||
2017
Q2 | $8.13M | Hold |
|
|||||
2017
Q1 | $12.7M | Buy |
|